Canada Pension Plan Investment Board’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15M Sell
213,808
-62,261
-23% -$3.22M 0.01% 599
2026
Q1
$14M Sell
276,069
-21,226
-7% -$990K 0.01% 568
2025
Q4
$8.77M Sell
297,295
-11,200
-4% -$304K 0.01% 678
2025
Q3
$7.97M Sell
308,495
-292,651
-49% -$8.16M 0.01% 684
2025
Q2
$16.6M Buy
601,146
+232,874
+63% +$6.13M 0.01% 503
2025
Q1
$10.4M Sell
368,272
-86,135
-19% -$3.06M 0.01% 560
2024
Q4
$18.9M Buy
454,407
+89,235
+24% +$4.26M 0.02% 476
2024
Q3
$24.4M Buy
365,172
+131,226
+56% +$12M 0.02% 412
2024
Q2
$27.8M Sell
233,946
-2,492
-1% -$315K 0.03% 372
2024
Q1
$25.2M Sell
236,438
-135,720
-36% -$13.7M 0.03% 407
2023
Q4
$37M Buy
372,158
+2,402
+0.6% +$202K 0.05% 307
2023
Q3
$38.2M Sell
369,756
-78,976
-18% -$8.81M 0.06% 275
2023
Q2
$54.5M Sell
448,732
-1,404
-0.3% -$187K 0.08% 225
2023
Q1
$69.1M Buy
450,136
+12,468
+3% +$2.06M 0.11% 192
2022
Q4
$78.6M Sell
437,668
-677,323
-61% -$111M 0.14% 151
2022
Q3
$132M Buy
1,114,991
+9,618
+0.9% +$1.46M 0.22% 110
2022
Q2
$158M Buy
1,105,373
+245,664
+29% +$35.1M 0.26% 96
2022
Q1
$148M Sell
859,709
-402,757
-32% -$67.8M 0.2% 124
2021
Q4
$321M Buy
1,262,466
+188,848
+18% +$55.2M 0.34% 80
2021
Q3
$413M Sell
1,073,618
-158,358
-13% -$58.4M 0.47% 54
2021
Q2
$289M Sell
1,231,976
-29,752
-2% -$5.32M 0.35% 76
2021
Q1
$165M Buy
1,261,728
+541,970
+75% +$78.5M 0.22% 121
2020
Q4
$75.2M Hold
719,758
0.11% 169
2020
Q3
$50.9M Sell
719,758
-512,100
-42% -$35.7M 0.1% 159
2020
Q2
$79.1M Sell
1,231,858
-1,157,615
-48% -$63.4M 0.17% 107
2020
Q1
$71.6M Buy
2,389,473
+789,473
+49% +$18.2M 0.19% 99
2019
Q4
$31.3M Hold
1,600,000
0.06% 237
2019
Q3
$25.5M Hold
1,600,000
0.05% 276
2019
Q2
$23.4M Hold
1,600,000
0.05% 305
2019
Q1
$32.6M Hold
1,600,000
0.06% 255
2018
Q4
$24.4M Buy
+1,600,000
New +$26.3M 0.05% 279

Other funds holding MRNA

Canada Pension Plan Investment Board's MRNA Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Moderna (MRNA) stake by 23% in Q2 2026, selling an estimated $3.22M and leaving 213,808 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #599.

Canada Pension Plan Investment Board first reported a position in MRNA in Q4 2018 and has held it in 31 quarters since. The position peaked at $413M in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Canada Pension Plan Investment Board held 213,808 shares of Moderna worth $15M as of Q2 2026.
  • Canada Pension Plan Investment Board sold 62,261 Moderna shares in Q2 2026, an estimated $3.22M.
  • Moderna made up 0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #599 holding.
  • Canada Pension Plan Investment Board first reported a position in Moderna in Q4 2018 and has held it in 31 quarters since.
  • Canada Pension Plan Investment Board's Moderna position peaked at $413M in Q3 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.